Epigenetic state determines the in vivo efficacy of STING agonist therapy
STING agonists have shown limited efficacy in early-phase clinical trials despite promising pre-clinical data. This study shows the potential clinical relevance of the use of combination STING agonists and demethylating agent therapies to induce the expression of STING.
| 出版年: | Nature Communications |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Nature Portfolio
2023-03-01
|
| オンライン・アクセス: | https://doi.org/10.1038/s41467-023-37217-1 |
